{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:30:06Z","timestamp":1789399806484,"version":"build-2803163510"},"reference-count":50,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T00:00:00Z","timestamp":1761782400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Angola is one of the countries with the highest prevalence of sickle cell disease (SCD). Neonatal SCD testing is recommended by the Angolan government, but it is not routinely performed. Nearly all previous studies of SCD have been conducted in cities. We implemented a neonatal SCD screening program in a referral hospital in Hu\u00edla province to examine the epidemiology of SCD in this Umbundu-speaking population and to demonstrate the feasibility of using point-of-care (POC) tests for SCD in a rural setting.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Between October 2024 and February 2025, we screened 353 infants less than one month old at Hospital Evang\u00e9lico de Caluquembe for the hemoglobin S (HbS) gene using HemoTypeSC rapid diagnostic tests. We also reviewed all pediatric outpatient visits from 2024 to identify newly-diagnosed SCD cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-one (6.0%) of the 353 neonates had sickle cell trait (HbAS); none had SCD (HbSS). The outpatient register review identified 26 incident cases of SCD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The prevalence of HbS is lower in Caluquembe than in Luanda and Cabinda, but the combined results of our newborn screening and pediatric records provide evidence that there is a burden of disease from SCD in Caluquembe and the surrounding areas. Sickle cell screening and treatment programs should be available in all high-burden areas, not just large cities. The per-test costs may still be too expensive for universal newborn screening to be scaled up nationwide, but our pilot study demonstrates that POC tests can be a cost-effective method that yields immediate results.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0335720","type":"journal-article","created":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:41:19Z","timestamp":1761846079000},"page":"e0335720","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":2,"title":["Newborn screening for sickle cell disease in Caluquembe, southwestern Angola, 2024\u20132025"],"prefix":"10.1371","volume":"20","author":[{"given":"Jasmine J.","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasco S.","family":"Kupua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4198-6246","authenticated-orcid":true,"given":"Kathryn H.","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,10,30]]},"reference":[{"issue":"17","key":"pone.0335720.ref001","doi-asserted-by":"crossref","first-page":"5538","DOI":"10.3390\/jcm12175538","article-title":"Systematic literature review shows gaps in data on global prevalence and birth prevalence of sickle cell disease and sickle cell trait: call for action to scale up and harmonize data collection","volume":"12","author":"R Colombatti","year":"2023","journal-title":"J Clin Med"},{"issue":"8","key":"pone.0335720.ref002","article-title":"Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: a systematic analysis from the Global Burden of Disease Study 2021","volume":"10","author":"GBD 2021 Sickle Cell Disease Collaborators.","year":"2023","journal-title":"Lancet Haematol"},{"issue":"1","key":"pone.0335720.ref003","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.4102\/ajlm.v12i1.2225","article-title":"Bridging the gaps in newborn screening programmes: challenges and opportunities to detect haemoglobinopathies in Africa","volume":"12","author":"S Twum","year":"2023","journal-title":"Afr J Lab Med"},{"key":"pone.0335720.ref004","doi-asserted-by":"crossref","DOI":"10.1016\/j.amepre.2011.09.013","article-title":"Sickle cell disease in Africa: a neglected cause of early childhood mortality","volume":"41","author":"SD Grosse","year":"2011","journal-title":"Am J Prev Med"},{"key":"pone.0335720.ref005","first-page":"56","article-title":"Sickle cell disease among children in Africa: an integrative literature review and global recommendations","volume":"3","author":"LL Mulumba","year":"2015","journal-title":"Int J Africa Nurs Sci"},{"issue":"2","key":"pone.0335720.ref006","doi-asserted-by":"crossref","first-page":"021103","DOI":"10.7189\/jogh.08.021103","article-title":"The global burden of sickle cell disease in children under five years of age: a systematic review and meta-analysis","volume":"8","author":"E Wastnedge","year":"2018","journal-title":"J Glob Health"},{"issue":"2","key":"pone.0335720.ref007","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.hoc.2015.11.005","article-title":"Sickle cell disease in sub-Saharan Africa","volume":"30","author":"TN Williams","year":"2016","journal-title":"Hematol Oncol Clin North Am"},{"key":"pone.0335720.ref008","year":"2024"},{"issue":"19","key":"pone.0335720.ref009","doi-asserted-by":"crossref","first-page":"5860","DOI":"10.1182\/bloodadvances.2023010631","article-title":"Early diagnosis of sickle cell disease at birth hospitals and vaccination centers in Angola using point-of-care tests","volume":"7","author":"HS Olaniyan","year":"2023","journal-title":"Blood Adv"},{"key":"pone.0335720.ref010","doi-asserted-by":"crossref","first-page":"18010","DOI":"10.1038\/nrdp.2018.10","article-title":"Sickle cell disease","volume":"4","author":"GJ Kato","year":"2018","journal-title":"Nat Rev Dis Primers"},{"issue":"8","key":"pone.0335720.ref011","article-title":"Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission","volume":"10","author":"FB Piel","year":"2023","journal-title":"Lancet Haematol"},{"issue":"4","key":"pone.0335720.ref012","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1053\/j.seminhematol.2023.08.002","article-title":"Current challenges and new approaches to implementing optimal management of sickle cell disease in sub-Saharan Africa","volume":"60","author":"M Ally","year":"2023","journal-title":"Semin Hematol"},{"issue":"4","key":"pone.0335720.ref013","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/17474086.2022.2063116","article-title":"Strategies to increase access to basic sickle cell disease care in low- and middle-income countries","volume":"15","author":"M Dua","year":"2022","journal-title":"Expert Rev Hematol"},{"issue":"2","key":"pone.0335720.ref014","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1182\/blood-2016-09-702324","article-title":"Sickle cell anemia in sub-Saharan Africa: advancing the clinical paradigm through partnerships and research","volume":"129","author":"PT McGann","year":"2017","journal-title":"Blood"},{"issue":"9","key":"pone.0335720.ref015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0305110","article-title":"Sustainability of newborn screening for sickle cell disease in resource-poor countries: a systematic review","volume":"19","author":"CO Okeke","year":"2024","journal-title":"PLoS One"},{"issue":"3","key":"pone.0335720.ref016","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-057623","article-title":"Enablers and barriers to newborn screening for sickle cell disease in Africa: results from a qualitative study involving programmes in six countries","volume":"12","author":"NM Archer","year":"2022","journal-title":"BMJ Open"},{"issue":"24","key":"pone.0335720.ref017","doi-asserted-by":"crossref","first-page":"6187","DOI":"10.1182\/bloodadvances.2022007698","article-title":"The consortium on newborn screening in Africa for sickle cell disease: study rationale and methodology","volume":"6","author":"NS Green","year":"2022","journal-title":"Blood Adv"},{"key":"pone.0335720.ref018","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s12913-016-1572-6","article-title":"Newborn screening and prophylactic interventions for sickle cell disease in 47 countries in sub-Saharan Africa: a cost-effectiveness analysis","volume":"16","author":"A Kuznik","year":"2016","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"pone.0335720.ref019","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1182\/hematology.2024000548","article-title":"Newborn screening initiatives for sickle cell disease in Africa","volume":"2024","author":"OE Nnodu","year":"2024","journal-title":"Hematol Am Soc Hematol Educ Program"},{"issue":"3","key":"pone.0335720.ref020","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s12687-020-00463-7","article-title":"Empowering newborn screening programs in African countries through establishment of an international collaborative effort","volume":"11","author":"Jr Therrell BL","year":"2020","journal-title":"J Community Genet"},{"issue":"6","key":"pone.0335720.ref021","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3026(24)00078-4","article-title":"Hydroxyurea dose optimisation for children with sickle cell anaemia in sub-Saharan Africa (REACH): extended follow-up of a multicentre, open-label, phase 1\/2 trial","volume":"11","author":"B Aygun","year":"2024","journal-title":"Lancet Haematol"},{"issue":"3","key":"pone.0335720.ref022","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1080\/03630269.2019.1647230","article-title":"Unusual \u03b2-Globin haplotype distribution in newborns from Bengo, Angola","volume":"43","author":"E Borges","year":"2019","journal-title":"Hemoglobin"},{"key":"pone.0335720.ref023","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1182\/blood-2024-203098","article-title":"First-year outcomes of newborn sickle cell disease screening in an Angolan hospital","volume":"144","author":"M Brito","year":"2024","journal-title":"Blood"},{"issue":"10","key":"pone.0335720.ref024","doi-asserted-by":"crossref","first-page":"5417","DOI":"10.3390\/ijerph18105417","article-title":"Genotypic diversity among Angolan children with sickle cell anemia","volume":"18","author":"M Delgadinho","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"pone.0335720.ref025","first-page":"857","article-title":"Zur Sichelzellerkrankung in der Volksrepublik Angola. 1. Mitteilung: Epidemiologie und klinische Aspekte.","volume":"114","author":"W Eggert","year":"1987","journal-title":"Folia Haematol Int Mag Klin Morphol Blutforsch"},{"issue":"3","key":"pone.0335720.ref026","doi-asserted-by":"crossref","first-page":"81","DOI":"10.22481\/odeere.v8i3.13863","article-title":"Sa\u00fade em cidade e territ\u00f3rio africano: o caso da Anemia Falciforme em Luanda-Angola","volume":"8","author":"BA Kikuchi","year":"2023","journal-title":"ODEERE Revista Internacional de Rela\u00e7\u00f5es \u00c9tnicas"},{"issue":"1","key":"pone.0335720.ref027","first-page":"35","article-title":"Prevalence of sickle cell disease in Kilamba Kiaxi Hospital, Luanda, Angola","volume":"19","author":"C Lussiana","year":"2012","journal-title":"Trop J Health Sci"},{"issue":"12","key":"pone.0335720.ref028","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/ajh.23578","article-title":"A prospective newborn screening and treatment program for sickle cell anemia in Luanda, Angola","volume":"88","author":"PT McGann","year":"2013","journal-title":"Am J Hematol"},{"issue":"6","key":"pone.0335720.ref029","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jpeds.2015.08.068","article-title":"A cost-effectiveness analysis of a pilot neonatal screening program for sickle cell anemia in the Republic of Angola","volume":"167","author":"PT McGann","year":"2015","journal-title":"J Pediatr"},{"issue":"1","key":"pone.0335720.ref030","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.aogh.2015.02.728","article-title":"Pilot program of newborn screening for sickle cell disease in Angola: Angola Sickle Cell Initiative (ASCI)","volume":"81","author":"D Nirenberg","year":"2015","journal-title":"Ann Global Health"},{"issue":"12","key":"pone.0335720.ref031","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1182\/blood.2022017051","article-title":"Hydroxyurea treatment is associated with lower malaria incidence in children with sickle cell anemia in sub-Saharan Africa","volume":"141","author":"P Olupot-Olupot","year":"2023","journal-title":"Blood"},{"issue":"8","key":"pone.0335720.ref032","doi-asserted-by":"crossref","DOI":"10.1097\/INF.0000000000003581","article-title":"Bacterial meningitis in children with sickle cell disease in Angola","volume":"41","author":"T Pelkonen","year":"2022","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"pone.0335720.ref033","first-page":"1004","article-title":"Sickle cell trait and blood groups (ABO and Rh) in Angolans submitted to hemoglobin electrophoresis","volume":"2","author":"ENM Sacomboio","year":"2020","journal-title":"Hematol Oncol Curr Res"},{"key":"pone.0335720.ref034","doi-asserted-by":"crossref","first-page":"102822","DOI":"10.1016\/j.bcmd.2023.102822","article-title":"Characterization of a cohort of Angolan children with sickle cell anemia treated with hydroxyurea","volume":"105","author":"B Santos","year":"2024","journal-title":"Blood Cells Mol Dis"},{"key":"pone.0335720.ref035","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/01.HS9.0000872924.83535.50","article-title":"Comparison of Sickle Scan and Hemotype SC as point-of-care newborn screening diagnostics for sickle cell disease in Luanda, Angola","volume":"6","author":"B Santos","year":"2022","journal-title":"HemaSphere"},{"issue":"6","key":"pone.0335720.ref036","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1111\/j.1442-200X.2012.03719.x","article-title":"Hearing loss in Angolan children with sickle-cell disease","volume":"54","author":"A Taipale","year":"2012","journal-title":"Pediatr Int"},{"issue":"4","key":"pone.0335720.ref037","first-page":"269","article-title":"Factors associated with sickle cell disease mortality among hospitalized Angolan children and adolescents","volume":"26","author":"JCC Van-Dunem","year":"2007","journal-title":"West Afr J Med"},{"issue":"12","key":"pone.0335720.ref038","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.27365","article-title":"Intermittent or uneven daily administration of low-dose hydroxyurea is effective in treating children with sickle cell anemia in Angola","volume":"65","author":"TM Chambers","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"pone.0335720.ref039","doi-asserted-by":"crossref","first-page":"45488","DOI":"10.1038\/srep45488","article-title":"A paper-based test for screening newborns for sickle cell disease","volume":"7","author":"NZ Piety","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"pone.0335720.ref040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144901","article-title":"Validation of a low-cost paper-based screening test for sickle cell anemia","volume":"11","author":"NZ Piety","year":"2016","journal-title":"PLoS One"},{"key":"pone.0335720.ref041","article-title":"Doen\u00e7a falciforme \u2013 aspetos cl\u00ednicos e laboratoriais: enquadramento da doen\u00e7a na realidade em Angola","author":"S Vikango","year":"2020","journal-title":"[master\u2019s thesis]. Gandra, Portugal: Instituto Universit\u00e1rio de Ci\u00eancias da Sa\u00fade, Cooperativa de Ensino Superior Polit\u00e9cnico e Universit\u00e1rio (CESPU)"},{"key":"pone.0335720.ref042","volume-title":"Resultados definitivos: Recenseamento geral da popula\u00e7\u00e3o e habita\u00e7\u00e3o \u2013 2014","author":"Instituto Nacional de Estatistica (INE).","year":"2016"},{"key":"pone.0335720.ref043","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.bcmd.2017.08.010","article-title":"The pressing need for point-of-care diagnostics for sickle cell disease: a review of current and future technologies","volume":"67","author":"PT McGann","year":"2017","journal-title":"Blood Cells Mol Dis"},{"key":"pone.0335720.ref044","article-title":"Funcionamento familiar e resposta dos pais \u00e0 doen\u00e7a dos filhos: estudo explorat\u00f3rio com crian\u00e7as angolanas com anemia falciforme e mal\u00e1ria","author":"AV Gabriel","journal-title":"[master\u2019s thesis]. Coimbra, Portugal: Universidade de Coimbra"},{"key":"pone.0335720.ref045","author":"Instituto Nacional de Estat\u00edstica (INE).","year":"2017"},{"issue":"4","key":"pone.0335720.ref046","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1111\/bjh.14298","article-title":"A rapid, inexpensive and disposable point-of-care blood test for sickle cell disease using novel, highly specific monoclonal antibodies","volume":"175","author":"CT Quinn","year":"2016","journal-title":"Br J Haematol"},{"issue":"1","key":"pone.0335720.ref047","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/bjh.17678","article-title":"Saving lives through early diagnosis: the promise and role of point of care testing for sickle cell disease","volume":"196","author":"D Dexter","year":"2022","journal-title":"Br J Haematol"},{"issue":"1","key":"pone.0335720.ref048","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/ajh.25305","article-title":"Point-of-care screening for sickle cell disease in low-resource settings: a multi-center evaluation of HemoTypeSC, a novel rapid test","volume":"94","author":"C Steele","year":"2019","journal-title":"Am J Hematol"},{"key":"pone.0335720.ref049","doi-asserted-by":"crossref","first-page":"826262","DOI":"10.3389\/fped.2022.826262","article-title":"Distribution of HbS allele and haplotypes in a multi-ethnic population of Guinea Bissau, West Africa: implications for public health screening","volume":"10","author":"M Martella","year":"2022","journal-title":"Front Pediatr"},{"key":"pone.0335720.ref050","doi-asserted-by":"crossref","first-page":"13","DOI":"10.11604\/pamj.2014.18.13.3280","article-title":"The ethnic distribution of sickle cell disease in Sudan","volume":"18","author":"MM Sabahelzain","year":"2014","journal-title":"Pan Afr Med J"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0335720","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T17:41:24Z","timestamp":1761846084000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0335720"}},"subtitle":[],"editor":[{"given":"Tomasz W.","family":"Kaminski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,10,30]]},"references-count":50,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2025,10,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0335720","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,30]]}}}